Holen Sie sich die Stockscreener-App
48.02
0.76%
0.36
Handel nachbörslich:
48.02
Schlusskurs vom Vortag:
$47.66
Offen:
$48.2
24-Stunden-Volumen:
405.70K
Relative Volume:
0.80
Marktkapitalisierung:
$1.48B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$131.74M
KGV:
11.41
EPS:
4.21
Netto-Cashflow:
$166.13M
1W Leistung:
-0.97%
1M Leistung:
-19.48%
6M Leistung:
-23.84%
1J Leistung:
-33.87%
1-Tages-Spanne:
$47.26
$48.60
1-Wochen-Bereich:
$46.00
$48.97
52-Wochen-Spanne:
$46.00
$78.58
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Vergleichen Sie CNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
48.02 | 1.48B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
CONMED Co. (NYSE:CNMD) Stock Holdings Lifted by Osterweis Capital Management Inc. - MarketBeat
LPL Financial LLC Sells 8,917 Shares of CONMED Co. (NYSE:CNMD) - Defense World
CONMED Co. (NYSE:CNMD) Shares Sold by Barclays PLC - MarketBeat
Raymond James Financial Inc. Invests $18.25 Million in CONMED Co. (NYSE:CNMD) - MarketBeat
Champlain Investment Partners LLC Sells 67,092 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Sets New 1-Year LowHere's Why - MarketBeat
Russell Investments Group Ltd. Has $1.20 Million Holdings in CONMED Co. (NYSE:CNMD) - Defense World
Franklin Resources Inc. Lowers Stock Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Insiders Placed Bullish Bets Worth US$544.1k - Yahoo Finance
Dean Investment Associates LLC Grows Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Trading Down 5.7%Should You Sell? - MarketBeat
Alliancebernstein L.P. Grows Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
June 20th Options Now Available For CONMED (CNMD) - Nasdaq
Neuberger Berman Group LLC Makes New Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED stock touches 52-week low at $50.34 amid market challenges - Investing.com
Trexquant Investment LP Buys Shares of 38,644 CONMED Co. (NYSE:CNMD) - MarketBeat
Analysts Set CONMED Co. (NYSE:CNMD) Price Target at $77.20 - MarketBeat
6,912 Shares in CONMED Co. (NYSE:CNMD) Acquired by Bryce Point Capital LLC - MarketBeat
Vanguard Group Inc. Grows Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Commonwealth Equity Services LLC Lowers Holdings in CONMED Co. (NYSE:CNMD) - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 6,300 CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Hits New 1-Year LowWhat's Next? - MarketBeat
13,830 Shares in CONMED Co. (NYSE:CNMD) Bought by Integrated Quantitative Investments LLC - MarketBeat
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - TradingView
Short Interest in CONMED Co. (NYSE:CNMD) Rises By 21.7% - MarketBeat
Clearbridge Investments LLC Has $37.16 Million Stake in CONMED Co. (NYSE:CNMD) - MarketBeat
KLP Kapitalforvaltning AS Invests $432,000 in CONMED Co. (NYSE:CNMD) - Defense World
CONMED stock touches 52-week low at $55.02 amid market challenges By Investing.com - Investing.com South Africa
CONMED stock touches 52-week low at $55.02 amid market challenges - Investing.com
Prudential Financial Inc. Has $3.32 Million Holdings in CONMED Co. (NYSE:CNMD) - Defense World
CONMED Sets Critical Q1 2025 Earnings Release Date: Key Details for Investors - Stock Titan
Congress Wealth Management LLC DE Has $598,000 Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Holdings Decreased by Thrivent Financial for Lutherans - Defense World
CONMED Co. (NYSE:CNMD) Shares Sold by HighTower Advisors LLC - Defense World
The past three years for CONMED (NYSE:CNMD) investors has not been profitable - Yahoo Finance
Bridge City Capital LLC Buys 7,597 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Swiss National Bank Increases Position in CONMED Co. (NYSE:CNMD) - Defense World
Proficio Capital Partners LLC Makes New $909,000 Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
Natixis Advisors LLC Increases Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):